Edison issues update on ReNeuron Group (RENE)
February 22, 2019 12:53 ET
|
Edison Investment Research Limited
LONDON, Feb. 22, 2019 (GLOBE NEWSWIRE) -- ReNeuron’s (RENE) announcement of early but exciting data on three patients in the clinical study of its human retinal progenitor cell (hRPC) product was...
Edison issues update on InMed Pharmaceuticals (IN)
February 14, 2019 08:02 ET
|
Edison Investment Research Limited
LONDON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- InMed (IN) recently reported results for the second quarter of FY19 and is on track to bring INM-750 for epidermolysis bullosa (EB) into the clinic by the...
Edison issues flash note on ReNeuron Group (RENE)
January 24, 2019 12:09 ET
|
Edison Investment Research Limited
LONDON, Jan. 24, 2019 (GLOBE NEWSWIRE) -- ReNeuron has announced the long-awaited dosing of the first patient in its placebo-controlled US Phase IIb (PISCES III) study in patients six to 12 months...
Equity markets generally improving for exploration stage mining companies; early-stage developers finding it tougher
January 23, 2019 08:00 ET
|
Edison Investment Research Limited
The key findings for the latest mining report from Edison Investment Research are: Many commodities show in-situ value accretion when moving projects from inferred through to measured resources,...
Edison issues outlook on 1Spatial (SPA)
January 22, 2019 07:59 ET
|
Edison Investment Research Limited
LONDON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- 1Spatial’s (SPA) transition plan appears to be on track. Recent contract wins, US trends and mobile solutions should both sustain growth and ensure it...
Edison issues outlook on ReNeuron Group (RENE)
December 21, 2018 08:18 ET
|
Edison Investment Research Limited
LONDON, Dec. 21, 2018 (GLOBE NEWSWIRE) -- ReNeuron’s (RENE) H119 results highlighted cash of £30.7m, allowing it to execute on its ongoing clinical trials, although execution will bring a funding...
Edison issues outlook on Cohort (CHRT)
December 20, 2018 10:22 ET
|
Edison Investment Research Limited
LONDON, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Following a challenging first half, Cohort (CHRT) has seen excellent order intake in recent months. These underpin anticipated sales for H219 and provide...
Edison issues initiation on ADL Bionatur Solutions (BNT)
December 10, 2018 08:31 ET
|
Edison Investment Research Limited
LONDON, Dec. 10, 2018 (GLOBE NEWSWIRE) -- ADL Bionatur Solutions (ADL-BS) was formed through the reverse takeover in April 2018 of contract manufacturing (CMO) and active pharmaceutical ingredient...
Edison issues outlook on Atossa Genetics (ATOS)
December 07, 2018 12:07 ET
|
Edison Investment Research Limited
LONDON, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics’s (ATOS) endoxifen programs are advancing in their respective breast health programs. The firm recently reported positive safety data from...
Edison issues update on International Stem Cell (ISCO)
December 04, 2018 07:48 ET
|
Edison Investment Research Limited
LONDON, Dec. 04, 2018 (GLOBE NEWSWIRE) -- International Stem Cell (ISCO) reported Q318 revenues of $3.2m, up 73.0% compared to Q317 mainly due to the biomedical business, which had quarterly...